LGX818 (Cas No. 1269440-17-6)

Product Quick Detail

Cas No.
1269440-17-6
Formula
C22H27ClFN7O4S
M.Wt
540.01
Purity
98%
Solubility
Solubility
Packaging
Fluorinated Bottles
Delivery
7 Days

LGX818 is an orally available mutated BRaf V600E inhibitor(IC50=0.3 nM) with potential antineoplastic activity.
  • Country: China (Mainland)
  • Market: European Union,Americas
  • Founded Year: 2009
  • Address: 武汉东湖高新区长城科技园光谷精工D栋402室
  • Contact: Rosie Liu

Shanghai Sun-shine bio-technology Co., Ltd

Enter between 20 to 3,000 characters. English only. Characters: 0 / 3000
submiting now We do inquire for you, please wait...